Los Angeles Capital Management’s Moderna MRNA Stock Holding History

Los Angeles Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$117K	Hold	1,664	–	–	﹤0.01%	1310
2026 Q1	$84.5K	Hold	1,664	–	–	﹤0.01%	1379
2025 Q4	$46.8K	Buy	+1,664	New	+$45.2K	﹤0.01%	1618
2024 Q3	–	Sell	-7,614	Closed	-$904K	–	1251
2024 Q2	$904K	Sell	7,614 -17,660	-70%	-$2.23M	﹤0.01%	684
2024 Q1	$2.69M	Buy	+25,274	New	+$2.55M	0.01%	435
2023 Q3	–	Sell	-1,708	Closed	-$208K	–	1191
2023 Q2	$208K	Sell	1,708 -25	-1%	-$3.33K	﹤0.01%	1112
2023 Q1	$266K	Sell	1,733 -32,927	-95%	-$5.43M	﹤0.01%	1046
2022 Q4	$6.23M	Sell	34,660 -42,408	-55%	-$6.93M	0.03%	349
2022 Q3	$9.11M	Sell	77,068 -72,955	-49%	-$11.1M	0.05%	284
2022 Q2	$21.4M	Sell	150,023 -207,467	-58%	-$29.7M	0.11%	174
2022 Q1	$61.6M	Buy	357,490 +239,093	+202%	+$40.3M	0.24%	97
2021 Q4	$30.1M	Sell	118,397 -27,375	-19%	-$8M	0.11%	162
2021 Q3	$56.1M	Sell	145,772 -95,047	-39%	-$35.1M	0.26%	88
2021 Q2	$56.6M	Buy	240,819 +16,228	+7%	+$2.9M	0.25%	91
2021 Q1	$29.4M	Sell	224,591 -66,612	-23%	-$9.65M	0.13%	161
2020 Q4	$30.4M	Buy	291,203 +248,239	+578%	+$25.1M	0.13%	143
2020 Q3	$3.04M	Sell	42,964 -8,019	-16%	-$559K	0.01%	452
2020 Q2	$3.27M	Buy	+50,983	New	+$2.79M	0.02%	491

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Los Angeles Capital Management's MRNA Position: Q2 2026 in Review

Los Angeles Capital Management held its Moderna (MRNA) position steady in Q2 2026 at 1,664 shares worth $117K. The position accounts for ﹤0.01% of the portfolio, ranked #1310.

Los Angeles Capital Management first reported a position in MRNA in Q2 2020 and has held it in 18 quarters since. The position peaked at $61.6M in Q1 2022. 784 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

Los Angeles Capital Management held 1,664 shares of Moderna worth $117K as of Q2 2026.
Los Angeles Capital Management left its Moderna share count unchanged in Q2 2026.
Moderna made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q2 2026, its #1310 holding.
Los Angeles Capital Management first reported a position in Moderna in Q2 2020 and has held it in 18 quarters since.
Los Angeles Capital Management's Moderna position peaked at $61.6M in Q1 2022.
784 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.